The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients

Renal Failure

Volumn 27, Issue 4, 2005, Pages 367-372

  Kadiroglu, Ali Kemal ^a   Yilmaz, Mehmet Emin ^a   Sit, Dede ^a   Kara, Ismail Hamdi ^a   Isikoglu, Bünyamin ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Hemodialysis; L carnitine; rHuEPO

Indexed keywords

BICARBONATE; CARNITINE; FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DIALYSATE; DIALYSIS MEMBRANE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; TRANSFERRIN SATURATION INDEX;

CARNITINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SUBCUTANEOUS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; PROBABILITY; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 22244461901     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-65296     Document Type: Article

References (37)

1. NKF-DOQI. Guideline 4-target hematocrit/hemoglobin for epoetin therapy. In Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure; http://www.kidney.org/professionals/doqi/doqi/ang4.html. (Accessed February 10, 2004.)
2. Bommer, J. Saving erythropoietin by administering L-carnitine? Nephrol. Dial. Transplant. 1999, 14 (12), 2819-2821.
3. Horl, W.H. Is there a role for adjuvant therapy in patients being treated with epoetin? Nephrol. Dial. Transplant. 1999, 14 (Suppl. 2), 50-60.
4. Rodríguez-Benítez, P. L-Carnitine in dialysis, more than a commercial affair. Nephrol. Dial. Transplant. 2000, 75, 1477-1478.
5. Hoppel, C.; Ferrari, R.; Dimorro, S.; Sherwood, G. The Physiological Role of L-Carnitine. L-Carnitine and It's Role in Medicine from Function to Therapy, Academic Press Ltd.: London, 1992; 5-21.
6. Evangeliou, A.; Vlassopoulos, D.A. Carnitine metabolism and deficit-when is supplementation necessary? Curr. Pharm. Biotechnol. 2003, 4 (3), 211-219.
7. Guarnieri, G.; Situlin, R.; Biolo, G. Carnitine metabolism in uremia. Am. J. Kidney Dis. 2001, 38 (4 Suppl. 1), S63-S67.
8. Bartel, L.L.; Hussey, J.L.; Shrago, E. Effect of dialysis on serum carnitine, free fat acids, and triglyceride levels in man and rat. Metabolism 1982, 31 (9), 944-947.
9. Bellinghieri, G.; Santoro, D.; Calvani, M.; Mallamace, A.; Savica, V. Carnitine and hemodialysis. Am. J. Kidney Dis. 2003, 41 (3 Suppl. 1), Sl 16-S122.
10. Debska-Slizien, A.; Owczarzak, A.; Kunicka, D.; Lysiak-Szydlowska, W.; Rutkowski, B. Plasma carnitine profile during chronic renal anemia treatment with recombinant human erythropoietin. Int. J. Artif. Organs 2003, 26 (1), 33-38.
11. de los Reyes, B.; Navarro, J.A.; Perez-Garcia, R.; Liras, A.; Campos, Y.; Bornstein, B.; Arenas, J. Effects of L-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophos pholipid acyltransferase in uremia. Am. J. Clin. Nutr. 1998, 67 (3), 386-390.
12. Nikolaos, S. Effect of L-carnitine supplementation on red blood cells deformability in hemodialysis patients. Ren. Fail. 2000, 22 (1), 73-80.
13. Labonia, W.D.; Morelli, J.R.; Gimenez, M.I.; Freuler, P.V.; Morelli, O.H. Effect of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patients. Kidney Int. 1987, 32 (5), 754-759.
14. Arduini, A.; Rossi, M.; Mancinelli, G.; Belfiglio, M.; Scurti, R.; Radatti, G.; Shohet, S.B. Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability. Life Sci. 1990, 47 (26), 2395-2400.
15. Matsumura, M.; Hatakeyama, S.; Koni, I.; Mabuchi, H.; Muramoto, H. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients. Nephron 1996, 72 (4), 574-578.
16. Rodriguez-Segade, S.; Alonso De la Pena, C.; Paz, M.; Novoa, D.; Romero, R.; Arcocha, V.; Del Rio, R. Carnitine concentrations in dialyzed and undialyzed patients with chronic renal insufficiency. Ann. Clin. Biochem. 1986, 23 (Pt 6), 671-675.
17. Vlassopoulos, D.A.; Hadjiyannakos, O.K.; Anogiatis, A.G.; Evageliou, A.E.; Santikou, A.V.; Noussias; C.V.; Papandreou, P.T.; Hadjiconstantinou, V.E: Carnitine action on red blood cell osmotic resistance in hemodialysis patients. J. Nephrol. 2002, 15 (1), 68-73.
18. Arduini, A. Carnitine and its acyl esters as secondary antioxidants. Am. Heart J. 1992, 123, 1726-1727
19. Mingardi, G.; Bizzi, A.; Cini, M.; Licini, R.; Mecca, G.; Garatini, S. Carnitine balance in hemodialyzed patients. Clin. Nephrol. 1980, 13, 269-270.
20. Lindberg, J.; Sadler, R.; Slowik, M. Clinical management of dialysis-related carnitine deficiency: three case studies. Nephrol. News Issues 2003, 17 (5), 73-78.
21. Donatelli, A.; Terrizzi, C.; Zummo, G.; Russo, V.; Bucalo, M.L.; Scarpinato, A. Effects of L-carnitine on chronic anemia and erythrocyte adenosine triphosphate concentration in hemodialysis patients. Curr. Ther. Res. 1987, 41, 620-624.
22. Wanner, C.; Horl, W.H. Carnitine abnormalities in patients with renal insufficiency: pathophysiological and therapeutic aspects. Nephron 1988, 50 (2), 89-102.
23. Kletzmayr, J.; Mayer, G.; Legenstein, E.; Heinz-Peer, G.; Leitha, T.; Horl, W.H.; Kovarik, J. Anemia and carnitine supplementation in hemodialyzed patients. Kidney Int. 1999, 69, S93-S106.
24. Leschke, M.; Rumpf, K.W.; Eisenhauer, T.; Fuchs, C.; Becker, K.; Kothe, U.; Scheler, F. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney Int. 1983, 24, S143-S146.
25. Hurot, J.M. Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. J. Am. Soc. Nephrol. 2002, 13 (3), 708-714.
26. Vesela, E.; Racek, J.; Trefil, L.; Jankovy'ch, V.; Pojer, M. Effect of L-carnitine supplementation in hemodialysis patients. Nephron 2001, 88 (3), 218-223.
27. Labonia, W.D. L-Carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am. J. Kidney Dis. 1995, 26 (5), 757-764.
28. Matsumoto, Y.; Amano, I.; Hirose, S.; Tsuruta, Y.; Hara, S.; Murata, M.; Imai, T. Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin. Blood Purif. 2001, 19 (1), 24-32.
29. Takeda, F.; Teikyo, H.; Mono, A.; Kuwata, S.; Matsusaki, K.; Sano, M. One case report in which oral L-carnitine supplementation showed efficacy in renal anemia in maintenance hemodialysis patient in EPO dose, The 43rd Annual Congress of Japanese Society for Dialysis Therapy, Yokohama, Japan, May 1998.
30. Albertazzi, A.; Capelli, P.; Di Paolo, B.; Pola, P.; Tondi, P.; Vaccario, O. Endocrine metabolic effects of L-carnitine in patients on regular dialysis treatment. Proc. Eur. Dial. Transplant Assoc. 1983, 19, 302-307.
31. Trovato, G.M.; Ginardi, V.; Di Marco, V.; Dell'Aira, A.; Corsi, M. Long-term L-carnitine treatment of chronic anemia of patients with end-stage renal failure. Curr. Ther. Res. 1982, 31, 1042-1049.
32. Kooistra, M.P.; Struyvenberg, A.; Van Es, A. The response of recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels. Nephron 1991, 57(1), 127-128.
33. Boran, M.; Dalva, I.; Gonenc, F.; Cetin, S. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease. Nephron 1996, 73 (2), 314-315.
34. Patrikarea, A.; Stamelou, K.; Ntaontaki, I.; Patadakis, I.T. The effect of combined L-carnitine and erythropoietin administration on the anemia and on the lipid profile of patients on hemodialysis. EDTA Annual Congress, Amsterdam, June 18-21, 1996; Abstracts. Nephrol. Dial. Transplant. 1996, 11, A262.
35. Karvadias, D.; Fortounas, C.; Tsouchnikas, J.; Vlachononasios, T.; Barboutis, K. Reduction of the cost of erythropoietin therapy by coadministration of L-carnitine in hemodialysis patients, EDTA 32nd Congress, Athens, Greece, 1995.
36. National Kidney Foundation. Clinical practice guide-lines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am. J. Kidney Dis. 2000, 35 (6 Suppl. 2), S1-S140.
37. Consensus group statement. Role of L-carnitine in treating renal dialysis patients. Dial. Transplant. 1994, 23, 177-181.